|
300411
By:
Jeff Dominitz
|
2:50 PM 08/12/2002
|
|
How Do The Laws Of Probability Constrain Legislative And Judicial Efforts To Stop Racial Profiling?
|
|
300516
By:
Vernon L. Chinchilli
|
10:35 AM 08/13/2002
|
|
Using Counterfactuals to Account for Treatment Failures in Clinical Trials
|
|
300632
By:
Katherine Fradette
|
9:05 AM 08/12/2002
|
|
Comparing the "Typical" Score Across Independent Treatment Groups
|
|
300321
By:
Charles F. Manski
|
10:35 AM 08/14/2002
|
|
Statistical Treatment Rules for Heterogeneous Populations
|
|
300671
By:
Tie-Hua Ng
|
11:35 AM 08/13/2002
|
|
Iterative Chi-Square Test for Equivalence of Multiple Treatment Groups
|
|
300688
By:
Brian L. Wiens
|
10:55 AM 08/13/2002
|
|
Equivalence of Multiple Treatments with a Control: Design and Analysis Issues
|
|
300694
By:
Leslie A. McClure
|
9:20 AM 08/14/2002
|
|
Designing Clinical Trials When Treatments Favor Different Endpoints
|
|
300741
By:
Boris Iglewicz
|
11:15 AM 08/13/2002
|
|
Multi-Treatment Equivalence Trials: Design and Analysis Considerations
|
|
300768
By:
Brent A. Johnson
|
8:35 AM 08/12/2002
|
|
Estimating Mean Response as a Function of Treatment Duration in an Observational Study where Treatment Duration may be Informatively Censored
|
|
300809
By:
Hui Quan
|
2:35 PM 08/11/2002
|
|
Treatment by stratum interaction test for equivalence trials
|
|
300953
By:
Sati Mazumdar
|
9:35 AM 08/15/2002
|
|
An Intent-to-Treat Analysis Using a Mixed Model Approach and Data Collected After Termination of Treatment Protocol
|
|
301055
By:
Paul C. Stark
|
2:45 PM 08/12/2002
|
|
A Hierarchical Model for Detecting Treatment Interaction in Meta-Regression of Individual Patient and Summary Data
|
|
300088
By:
Gary L. Gadbury
|
2:30 PM 08/13/2002
|
|
Individual Treatment Variability in Clinical Experiments and the Implications for Genetic Studies
|
|
301120
By:
Stephen J. Senn
|
11:15 AM 08/12/2002
|
|
Practical Issues in Planning Cross-over Trials in Drug Development
|
|
301173
By:
Bruno Betro'
|
10:35 AM 08/13/2002
|
|
The Accelerated Central Cutting Plane Algorithm in the Numerical Treatment of Bayesian Global Prior Robustness Problems
|
|
301178
By:
Yi Cheng
|
11:35 AM 08/12/2002
|
|
Asymptotic Optimal Sample Sizes for Discovering Promising Treatment in Phase II Group Sequential Clinical Trials.
|
|
301180
By:
Christopher H. Schmid
|
2:25 PM 08/12/2002
|
|
Using the Control Rate to Explore Heterogeneity of Treatment Effects in Clinical Trials
|
|
301279
By:
Stephen R. Wisniewski
|
11:15 AM 08/14/2002
|
|
A Method of Incorporating Subject and Clinician Preferences in Random Treatment Allocation
|
|
301321
By:
Samuel Wieand
|
11:50 AM 08/13/2002
|
|
Looking for Treatment Effect in Genetic Sub-studies of Randomized Trials: Do We Need to Genotype Controls?
|
|
301360
By:
Alan M. Polansky
|
8:35 AM 08/14/2002
|
|
Optimal Treatment Selection in Designed Experiments
|
|
301417
By:
David C. Higdon
|
2:50 PM 08/14/2002
|
|
Treatment of Edge Effects in Spatial Data Analysis via Bayesian Markov Field Process Convolution Models
|
|
301533
By:
Edward Boone
|
3:05 PM 08/13/2002
|
|
Missing Covariate Treatment in Ecological Data
|
|
301650
By:
Pai-Lien Chen
|
08/13/2002
|
|
Poster # 11
A Method to Assess the Proportion of Treatment Effect Explained by a Time Dependent Surrogate Endpoint
|
|
301692
By:
Yili Lu
|
2:05 PM 08/12/2002
|
|
Duration Estimation for A Treatment-Emergent Adverse Event
|
|
301792
By:
Lev S. Sverdlov
|
5:05 PM 08/11/2002
|
|
Retention in Substance Abuse Treatment: Multivariate Analysis Using the Alcohol and Drug Services Survey (ADSS).
|
|
301927
By:
Mohamed Alosh
|
12:05 PM 08/12/2002
|
|
Testing for Treatment Effect in Clinical Trials with Multidimensional Longitudinal Data
|
|
301930
By:
Sue-Jane Wang
|
9:50 AM 08/12/2002
|
|
Evaluation of Treatment Effect Based on Recurrent Events Data with Censoring
|
|
